SM
Sabby Management’s VistaGen Therapeutics VTGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Hold |
0
| – | – | – | 104 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 96 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 122 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 137 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 128 |
|
|
2018
Q2 | – | Sell |
-143,486
| Closed | -$133K | – | 122 |
|
|
2018
Q1 | $133K | Sell |
143,486
-1,972,387
| -93% | -$1.83M | 0.02% | 74 |
|
|
2017
Q4 | $2.35M | Buy |
+2,115,873
| New | +$2.35M | 0.21% | 9 |
|
|
2017
Q3 | – | Sell |
-25,537
| Closed | -$48K | – | 138 |
|
|
2017
Q2 | $48K | Sell |
25,537
-147,942
| -85% | -$278K | ﹤0.01% | 103 |
|
|
2017
Q1 | $340K | Sell |
173,479
-2,905
| -2% | -$5.69K | 0.02% | 92 |
|
|
2016
Q4 | $658K | Sell |
176,384
-172,712
| -49% | -$644K | 0.04% | 75 |
|
|
2016
Q3 | $1.45M | Sell |
349,096
-274,221
| -44% | -$1.14M | 0.05% | 48 |
|
|
2016
Q2 | $2.43M | Buy |
+623,317
| New | +$2.43M | 0.13% | 35 |
|